rs144138766

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_014244.5(ADAMTS2):​c.2893G>A​(p.Glu965Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000343 in 1,608,298 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00036 ( 1 hom. )

Consequence

ADAMTS2
NM_014244.5 missense

Scores

4
7
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 7.68
Variant links:
Genes affected
ADAMTS2 (HGNC:218): (ADAM metallopeptidase with thrombospondin type 1 motif 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase. This proteinase excises the N-propeptide of the fibrillar procollagens types I-III and type V. Mutations in this gene cause Ehlers-Danlos syndrome type VIIC, a recessively inherited connective-tissue disorder. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.011239171).
BP6
Variant 5-179125038-C-T is Benign according to our data. Variant chr5-179125038-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 469674.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.000357 (520/1456470) while in subpopulation AMR AF= 0.00508 (221/43484). AF 95% confidence interval is 0.00453. There are 1 homozygotes in gnomad4_exome. There are 214 alleles in male gnomad4_exome subpopulation. Median coverage is 38. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ADAMTS2NM_014244.5 linkuse as main transcriptc.2893G>A p.Glu965Lys missense_variant 19/22 ENST00000251582.12 NP_055059.2
ADAMTS2XM_047417895.1 linkuse as main transcriptc.2398G>A p.Glu800Lys missense_variant 18/21 XP_047273851.1
ADAMTS2XM_047417896.1 linkuse as main transcriptc.2011G>A p.Glu671Lys missense_variant 17/20 XP_047273852.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ADAMTS2ENST00000251582.12 linkuse as main transcriptc.2893G>A p.Glu965Lys missense_variant 19/221 NM_014244.5 ENSP00000251582 P2O95450-1
ADAMTS2ENST00000518335.3 linkuse as main transcriptc.2893G>A p.Glu965Lys missense_variant 19/213 ENSP00000489888 A2
ADAMTS2ENST00000698889.1 linkuse as main transcriptc.2893G>A p.Glu965Lys missense_variant, NMD_transcript_variant 19/21 ENSP00000514008

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
151710
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000194
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000736
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000944
AC:
234
AN:
247778
Hom.:
1
AF XY:
0.000744
AC XY:
100
AN XY:
134494
show subpopulations
Gnomad AFR exome
AF:
0.000126
Gnomad AMR exome
AF:
0.00583
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000548
Gnomad SAS exome
AF:
0.000164
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000215
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000357
AC:
520
AN:
1456470
Hom.:
1
Cov.:
38
AF XY:
0.000295
AC XY:
214
AN XY:
724628
show subpopulations
Gnomad4 AFR exome
AF:
0.000270
Gnomad4 AMR exome
AF:
0.00508
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000510
Gnomad4 SAS exome
AF:
0.0000701
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000247
Gnomad4 OTH exome
AF:
0.000133
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
151828
Hom.:
0
Cov.:
33
AF XY:
0.000162
AC XY:
12
AN XY:
74186
show subpopulations
Gnomad4 AFR
AF:
0.000193
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000736
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000426
Hom.:
0
Bravo
AF:
0.000555
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000817
AC:
99
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ehlers-Danlos syndrome, dermatosparaxis type Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityApr 25, 2022- -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 05, 2021- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2022- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 08, 2024The c.2893G>A (p.E965K) alteration is located in exon 19 (coding exon 19) of the ADAMTS2 gene. This alteration results from a G to A substitution at nucleotide position 2893, causing the glutamic acid (E) at amino acid position 965 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
ADAMTS2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 18, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.61
D;.
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Benign
0.079
D
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-0.49
T
MutationAssessor
Uncertain
2.4
M;.
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.3
D;.
REVEL
Uncertain
0.43
Sift
Benign
0.079
T;.
Sift4G
Uncertain
0.028
D;.
Polyphen
1.0
D;.
Vest4
0.89
MVP
0.63
MPC
1.3
ClinPred
0.073
T
GERP RS
5.3
Varity_R
0.33
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144138766; hg19: chr5-178552039; COSMIC: COSV52363790; COSMIC: COSV52363790; API